Pyxis Oncology, Inc. (PYXS) Free cash flow 2020–2025
Pyxis Oncology, Inc. (PYXS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$63.5MFY2025 · since FY2020: -$11.6M → -$63.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.5M | -9.7% |
| FY2024 | -$57.9M | +25.2% |
| FY2023 | -$77.4M | +19.1% |
| FY2022 | -$95.7M | -166.9% |
| FY2021 | -$35.9M | -210.1% |
| FY2020 | -$11.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →